Home
UPLIFT® - Study Population

The UPLIFT study include 5993 COPD patients in
37 countries on all continents.

Commencing in December 2002, patient
inclusion/exclusion criteria had been as follows:

table 1


table 2


References can be found here


PfizerBoehringer Ingelheim
SitemapTerms of UseImprintPfizerBoehringer Ingelheim